---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-068406"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:11:21.003668+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Acadia discloses $9.2M total exposure to failed Silicon Valley Bank

## Summary
- Approximately $1M in deposit accounts at SVB for daily cash needs as of March 10, 2023.
- Approximately $5.8M in restricted cash in money-market accounts as collateral for office leases and corporate charge card.
- Approximately $2.4M in receivables in a lockbox account at SVB.
- Company states exposure to SVB is limited; total disclosed exposure about $9.2M.

## SEC filing metadata
- accession: 0001193125-23-068406
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312523068406/0001193125-23-068406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312523068406/d409752d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-068406
- JSON: https://secwatch.observer/filing/0001193125-23-068406.json
- Plain text: https://secwatch.observer/filing/0001193125-23-068406.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.